Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HYNES NE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 64 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hynes, NE; Horsch, K; Olayioye, MA; Badache, A
      The ErbB receptor tyrosine family as signal integrators

      ENDOCRINE-RELATED CANCER
    2. Hynes, NE; Lane, HA
      Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptortyrosine kinase

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    3. Brandt, R; Wong, AML; Hynes, NE
      Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells providea novel orthotopic tumor model for testing anti-cancer agents

      ONCOGENE
    4. Neve, RM; Lane, HA; Hynes, NE
      The role of overexpressed HER2 in transformation

      ANNALS OF ONCOLOGY
    5. Lane, HA; Motoyama, AB; Beuvink, I; Hynes, NE
      Modulation of p27/Cdk2 complex formation through 4D5-mediated inhibition of HER2 receptor signaling

      ANNALS OF ONCOLOGY
    6. Horsch, K; Schaller, MD; Hynes, NE
      The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells

      MOLECULAR ENDOCRINOLOGY
    7. Olayioye, MA; Badache, A; Daly, JM; Hynes, NE
      An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway

      EXPERIMENTAL CELL RESEARCH
    8. Badache, A; Hynes, NE
      Interleukin 6 inhibits proliferation and, in cooperation with an epidermalgrowth factor receptor autocrine loop, increases migration of T47D breast cancer cells

      CANCER RESEARCH
    9. Hynes, NE
      Tyrosine kinase signalling in breast cancer

      BREAST CANCER RESEARCH
    10. Yen, L; You, XL; Al Moustafa, AE; Batist, G; Hynes, NE; Mader, S; Meloche, S; Alaoui-Jamali, MA
      Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis

      ONCOGENE
    11. Neve, RM; Sutterluty, H; Pullen, N; Lane, HA; Daly, JM; Krek, W; Hynes, NE
      Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

      ONCOGENE
    12. Cella, N; Chiquet-Ehrismann, R; Hynes, NE
      Lactogenic hormones and tenascin-C regulate C/EBP alpha and beta in mammary epithelial cells

      JOURNAL OF CELLULAR BIOCHEMISTRY
    13. Lane, HA; Beuvink, I; Motoyama, AB; Daly, JM; Neve, RM; Hynes, NE
      ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: Receptor overexpression does not determine growth dependency

      MOLECULAR AND CELLULAR BIOLOGY
    14. Olayioye, MA; Neve, RM; Lane, HA; Hynes, NE
      The ErbB signaling network: receptor heterodimerization in development andcancer

      EMBO JOURNAL
    15. Spencer, KSR; Graus-Porta, D; Leng, J; Hynes, NE; Klemke, RL
      ErbB2 is necessary for induction of carcinoma cell invasion by ErbB familyreceptor tyrosine kinases

      JOURNAL OF CELL BIOLOGY
    16. Beuvink, I; Hess, D; Flotow, H; Hofsteenge, J; Groner, B; Hynes, NE
      Stat5a serine phosphorylation - Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Daly, JM; Olayioye, MA; Wong, AML; Neve, R; Lane, HA; Maurer, FG; Hynes, NE
      NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways

      ONCOGENE
    18. Klapper, LN; Glathe, S; Vaisman, N; Hynes, NE; Andrews, GC; Sela, M; Yarden, Y
      The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    19. Olayioye, MA; Beuvink, I; Horsch, K; Daly, JM; Hynes, NE
      ErbB receptor-induced activation of Stat transcription factors is mediatedby Src tyrosine kinases

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. NEVE R; CHANG CH; SCOTT GK; WONG A; FRIIS RR; HYNES NE; BENZ CC
      THE EPITHELIUM-SPECIFIC ETS TRANSCRIPTION FACTOR ESX IS ASSOCIATED WITH MAMMARY-GLAND DEVELOPMENT AND INVOLUTION

      The FASEB journal
    21. OLAYIOYE MA; GRAUSPORTA D; BEERLI RR; ROHRER J; GAY B; HYNES NE
      ERBB-1 AND ERBB-2 ACQUIRE DISTINCT SIGNALING PROPERTIES DEPENDENT UPON THEIR DIMERIZATION PARTNER

      Molecular and cellular biology
    22. CELLA N; GRONER B; HYNES NE
      CHARACTERIZATION OF STAT5A AND STAT5B HOMODIMERS AND HETERODIMERS ANDTHEIR ASSOCIATION WITH THE GLUCOCORTIOCOID RECEPTOR IN MAMMARY CELLS

      Molecular and cellular biology
    23. MERLO GR; FIORE L; BASOLO F; WOODSCOOK K; HYNES NE
      IN MAMMARY EPITHELIAL-CELLS P53-MEDIATED APOPTOSIS IN RESPONSE TO DNA-DAMAGE IS DEPENDENT ON THE AGENT AND CAN BE INFLUENCED BY GROWTH-FACTORS

      Endocrine-related cancer
    24. MERLO GR; CELLA N; HYNES NE
      APOPTOSIS IS ACCOMPANIED BY CHANGES IN BCL-2 AND BAX EXPRESSION, INDUCED BY LOSS OF ATTACHMENT, AND INHIBITED BY SPECIFIC EXTRACELLULAR-MATRIX PROTEINS IN MAMMARY EPITHELIAL-CELLS

      Cell growth & differentiation
    25. HYNES NE
      THE ERB-B FAMILY OF RECEPTOR TYROSINE KINASES - THEIR ROLE IN CANCER DEVELOPMENT AND AS TARGETS FOR THERAPY

      European journal of cancer
    26. GRAUSPORTA D; BEERLI RR; DALY JM; HYNES NE
      ERBB-2, THE PREFERRED HETERODIMERIZATION PARTNER OF ALL ERBB RECEPTORS, IS A MEDIATOR OF LATERAL SIGNALING

      EMBO journal
    27. WARTMANN M; HOFER P; TUROWSKI P; SALTIEL AR; HYNES NE
      NEGATIVE MODULATION OF MEMBRANE LOCALIZATION OF THE RAF-1 PROTEIN-KINASE BY HYPERPHOSPHORYLATION

      The Journal of biological chemistry
    28. DALY JM; JANNOT CB; BEERLI RR; GRAUSPORTA D; MAURER FG; HYNES NE
      NEU DIFFERENTIATION FACTOR INDUCES ERBB2 DOWN-REGULATION AND APOPTOSIS OF ERBB2-OVEREXPRESSING BREAST-TUMOR CELLS

      Cancer research
    29. JANNOT CB; HYNES NE
      CHARACTERIZATION OF SCFV-421, A SINGLE-CHAIN ANTIBODY-TARGETED TO P53

      Biochemical and biophysical research communications
    30. JANNOT CB; BEERLI RR; MASON S; GULLICK WJ; HYNES NE
      INTRACELLULAR EXPRESSION OF A SINGLE-CHAIN ANTIBODY-DIRECTED TO THE EGFR LEADS TO GROWTH-INHIBITION OF TUMOR-CELLS

      Oncogene
    31. BACUS SS; YARDEN Y; OREN M; CHIN DM; LYASS L; ZELNICK CR; KAZAROV A; TOYOFUKU W; GRAYBABLIN J; BEERLI RR; HYNES NE; NIKIFOROV M; HAFFNER R; GUDKOV A; KEYOMARSI K
      NEU DIFFERENTIATION FACTOR (HEREGULIN) ACTIVATES A P53-DEPENDENT PATHWAY IN CANCER-CELLS

      Oncogene
    32. CELLA N; CORNEJOURIBE RR; MONTES GS; HYNES NE; CHAMMAS R
      THE LYSOSOMAL-ASSOCIATED MEMBRANE-PROTEIN LAMP-1 IS A NOVEL DIFFERENTIATION MARKER FOR HC11 MOUSE MAMMARY EPITHELIAL-CELLS

      Differentiation
    33. KARUNAGARAN D; TZAHAR E; BEERLI RR; CHEN XM; GRAUSPORTA D; RATZKIN BJ; SEGER R; HYNES NE; YARDEN Y
      ERBB-2 IS A COMMON AUXILIARY SUBUNIT OF NDF AND EGF RECEPTORS - IMPLICATIONS FOR BREAST-CANCER

      EMBO journal
    34. BEERLI RR; WELS W; HYNES NE
      INHIBITION OF SIGNALING FROM TYPE-1 RECEPTOR TYROSINE KINASES VIA INTRACELLULAR EXPRESSION OF SINGLE-CHAIN ANTIBODIES

      Breast cancer research and treatment
    35. WARTMANN M; CELLA N; HOFER P; GRONER B; LIU XW; HENNIGHAUSEN L; HYNES NE
      LACTOGENIC HORMONE ACTIVATION OF STAT5 AND TRANSCRIPTION OF THE BETA-CASEIN GENE IN MAMMARY EPITHELIAL-CELLS IS INDEPENDENT OF P42 ERK2 MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVITY

      The Journal of biological chemistry
    36. BEERLI RR; HYNES NE
      EPIDERMAL GROWTH FACTOR-RELATED PEPTIDES ACTIVATE DISTINCT SUBSETS OFERBB RECEPTORS AND DIFFER IN THEIR BIOLOGICAL-ACTIVITIES

      The Journal of biological chemistry
    37. SCHMIDT M; HYNES NE; GRONER B; WELS W
      A BIVALENT SINGLE-CHAIN ANTIBODY TOXIN SPECIFIC FOR ERBB-2 AND THE EGF RECEPTOR

      International journal of cancer
    38. HYNES NE; GRONER B
      A TARGET FOR TUMOR-DIRECTED THERAPY

      Nature medicine
    39. HYNES NE; BEERLI R; GRAUSPORTA D; WEIS W
      TYPE-I RECEPTOR TYROSINE KINASES AS TARGETS FOR CANCER-THERAPY

      European journal of cancer
    40. SCHMIDT M; HYNES NE; GRONER B; WELS W
      RECOMBINANT SINGLE-CHAIN IMMUNOTOXINS SPECIFIC FOR THE EGF RECEPTOR AND ERBB-2

      European journal of cancer
    41. MARTE BM; GRAUSPORTA D; JESCHKE M; FABBRO D; HYNES NE; TAVERNA D
      NDF HEREGULIN ACTIVATES MAP KINASE AND P70 P85 S6 KINASE DURING PROLIFERATION OR DIFFERENTIATION OF MAMMARY EPITHELIAL-CELLS/

      Oncogene
    42. MARTE BM; JESCHKE M; GRAUSPORTA D; TAVERNA D; HOFER P; GRONER B; YARDEN Y; HYNES NE
      NEU DIFFERENTIATION FACTOR HEREGULIN MODULATES GROWTH AND DIFFERENTIATION OF HC11 MAMMARY EPITHELIAL-CELLS

      Molecular endocrinology
    43. WELS W; MORITZ D; SCHMIDT M; JESCHKE M; HYNES NE; GRONER B
      BIOTECHNOLOGICAL AND GENE THERAPEUTIC STRATEGIES IN CANCER-TREATMENT

      Gene
    44. GRAUSPORTA D; BEERLI RR; HYNES NE
      SINGLE-CHAIN ANTIBODY-MEDIATED INTRACELLULAR RETENTION OF ERBB-2 IMPAIRS NEU DIFFERENTIATION FACTOR AND EPIDERMAL GROWTH-FACTOR SIGNALING

      Molecular and cellular biology
    45. BEERLI RR; GRAUSPORTA D; WOODSCOOK K; CHEN XM; YARDEN Y; HYNES NE
      NEU DIFFERENTIATION FACTOR ACTIVATION OF ERBB-3 AND ERBB-4 IS CELL-SPECIFIC AND DISPLAYS A DIFFERENTIAL REQUIREMENT FOR ERBB-2

      Molecular and cellular biology
    46. MERLO GR; BASOLO F; FIORE L; DUBOC L; HYNES NE
      P53-DEPENDENT AND P53-INDEPENDENT ACTIVATION OF APOPTOSIS IN MAMMARY EPITHELIAL-CELLS REVEALS A SURVIVAL FUNCTION OF EGF AND INSULIN

      The Journal of cell biology
    47. WELS W; BEERLI R; HELLMANN P; SCHMIDT M; MARTE BM; KORNILOVA ES; HEKELE A; MENDELSOHN J; GRONER B; HYNES NE
      EGF RECEPTOR AND P185(ERB-2)-SPECIFIC SINGLE-CHAIN ANTIBODY TOXINS DIFFER IN THEIR CELL-KILLING ACTIVITY ON TUMOR-CELLS EXPRESSING BOTH RECEPTOR PROTEINS

      International journal of cancer
    48. MARTE BM; MEYER T; STABEL S; STANDKE GJR; JAKEN S; FABBRO D; HYNES NE
      PROTEIN-KINASE-C AND MAMMARY CELL-DIFFERENTIATION - INVOLVEMENT OF PROTEIN-KINASE-C-ALPHA IN THE INDUCTION OF BETA-CASEIN EXPRESSION

      Cell growth & differentiation
    49. MERLO GR; HYNES NE
      COOPERATION BETWEEN MUTANT P53 AND THE RAS, RAF, ERBB-2 AND FGF-3 ONCOGENES FOR TRANSFORMATION OF MAMMARY EPITHELIAL-CELLS

      International journal of oncology
    50. MERLO GR; VENESIO T; TAVERNA D; MARTE BM; CALLAHAN R; HYNES NE
      GROWTH SUPPRESSION OF NORMAL MAMMARY EPITHELIAL-CELLS BY WILD-TYPE P53

      Oncogene
    51. HYNES NE; MARTE BM; HELLMANN P; BEERLI R; GRONER B; WELS W
      RECOMBINANT SINGLE-CHAIN IMMUNOTOXINS SPECIFIC FOR EGF AND ERBB-2 RECEPTORS INHIBIT IN-VIVO AND IN-VITRO TUMOR-CELL GROWTH

      Journal of cellular biochemistry
    52. HYNES NE; STERN DF
      THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER

      Biochimica et biophysica acta, CR. Reviews on cancer
    53. MESSERLE K; SCHLEGEL J; HYNES NE; GRONER B
      NIH 3T3 CELLS TRANSFORMED WITH THE ACTIVATED ERBB-2 ONCOGENE CAN BE PHENOTYPICALLY REVERTED BY A KINASE DEFICIENT, DOMINANT-NEGATIVE ERBB-2VARIANT/

      Molecular and cellular endocrinology
    54. SCHLEGEL J; STUMM G; BRANDLE K; MERDES A; MECHTERSHEIMER G; HYNES NE; KIESSLING M
      AMPLIFICATION AND DIFFERENTIAL EXPRESSION OF MEMBERS OF THE ERBB-GENEFAMILY IN HUMAN GLIOBLASTOMA

      Journal of neuro-oncology
    55. CHAMMAS R; TAVERNA D; CELLA N; SANTOS C; HYNES NE
      LAMININ AND TENASCIN ASSEMBLY AND EXPRESSION REGULATE HC11 MOUSE MAMMARY CELL-DIFFERENTIATION

      Journal of Cell Science
    56. BEERLI RR; WELS W; HYNES NE
      INTRACELLULAR EXPRESSION OF SINGLE-CHAIN ANTIBODIES REVERTS ERBB-2 TRANSFORMATION

      The Journal of biological chemistry
    57. TAVERNA D; ANTONIOTTI S; MAGGIORA P; DATI C; DEBORTOLI M; HYNES NE
      ERBB-2 EXPRESSION IN ESTROGEN-RECEPTOR-POSITIVE BREAST-TUMOR CELLS ISREGULATED BY GROWTH-MODULATORY REAGENTS

      International journal of cancer
    58. CHAMMAS R; CELLA N; MARQUES LA; BRENTANI RR; HYNES NE; FRANCO ELF
      BETA-1-6 BRANCHED OLIGOSACCHARIDES AS A MARKER OF TUMOR PROGRESSION IN HUMAN BREAST AND COLON NEOPLASIA

      Cancer research
    59. ANTONIOTTI S; TAVERNA D; MAGGIORA P; SAPEI ML; HYNES NE; DEBORTOLI M
      ESTROGEN AND EPIDERMAL GROWTH-FACTOR DOWN-REGULATE ERBB-2 ONCOGENE PROTEIN EXPRESSION IN BREAST-CANCER CELLS BY DIFFERENT MECHANISMS

      British Journal of Cancer
    60. BEERLI RR; WELS W; HYNES NE
      AUTOCRINE INHIBITION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR BY INTRACELLULAR EXPRESSION OF A SINGLE-CHAIN ANTIBODY

      Biochemical and biophysical research communications
    61. BEERLI RR; WELS W; HYNES NE
      AUTOCRINE INHIBITION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR BY INTRACELLULAR EXPRESSION OF A SINGLE-CHAIN ANTIBODY

      Biochemical and biophysical research communications
    62. KIRJAVAINEN J; LEPPA S; HYNES NE; JALKANEN M
      TRANSLATIONAL SUPPRESSION OF SYNDECAN-1 EXPRESSION IN HA-RAS TRANSFORMED MOUSE MAMMARY EPITHELIAL-CELLS

      Molecular biology of the cell
    63. HARWERTH IM; WELS W; SCHLEGEL J; MULLER M; HYNES NE
      MONOCLONAL-ANTIBODIES DIRECTED TO THE ERBB-2 RECEPTOR INHIBIT IN-VIVOTUMOR-CELL GROWTH

      British Journal of Cancer
    64. SCHLEGEL J; ULLRICH B; STUMM G; GASS P; HARWERTH IM; HYNES NE; KIESSLING M
      EXPRESSION OF THE C-ERBB-2-ENCODED ONCOPROTEIN AND PROGESTERONE-RECEPTOR IN HUMAN MENINGIOMAS

      Acta Neuropathologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 10:41:58